FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2591778805> ?p ?o ?g. }

• W2591778805 endingPage "1123" @default.
• W2591778805 startingPage "1114" @default.
• W2591778805 abstract "To address the need for efficient and biocompatible delivery systems for systemic siRNA delivery, we developed 1,2-Dioleoyl-sn-Glycero-3-Phosphatidylcholine (DOPC) nanoliposomal EphA2-targeted therapeutic (EPHARNA). Here, we performed safety studies of EPHARNA in murine and primate models. Single dosing of EPHARNA was tested at 5 concentrations in mice (N = 15 per group) and groups were sacrificed on days 1, 14, and 28 for evaluation of clinical pathology and organ toxicity. Multiple dosing of EPHARNA was tested in mice and Rhesus macaques twice weekly at two dose levels in each model. Possible effects on hematologic parameters, serum chemistry, coagulation, and organ toxicity were assessed. Following single-dose EPHARNA administration to mice, no gross pathologic or dose-related microscopic findings were observed in either the acute (24 hours) or recovery (14 and 28 days) phases. The no-observed-adverse-effect level (NOAEL) for EPHARNA is considered >225 μg/kg when administered as a single injection intravenously in CD-1 mice. With twice weekly injection, EPHARNA appeared to stimulate a mild to moderate inflammatory response in a dose-related fashion. There appeared to be a mild hemolytic reaction in the female mice. In Rhesus macaques, minimal to moderate infiltration of mononuclear cells was found in some organs including the gastrointestinal tract, heart, and kidney. No differences attributed to EPHARNA were observed. These results demonstrate that EPHARNA is well tolerated at all doses tested. These data, combined with previously published in vivo validation studies, have led to an ongoing first-in-human phase I clinical trial (NCT01591356). Mol Cancer Ther; 16(6); 1114-23. ©2017 AACR." @default.
• W2591778805 created "2017-03-16" @default.
• W2591778805 creator A5009234043 @default.
• W2591778805 creator A5010129570 @default.
• W2591778805 creator A5012481606 @default.
• W2591778805 creator A5015483526 @default.
• W2591778805 creator A5020081483 @default.
• W2591778805 creator A5023542865 @default.
• W2591778805 creator A5027588399 @default.
• W2591778805 creator A5034494201 @default.
• W2591778805 creator A5037364493 @default.
• W2591778805 creator A5066527642 @default.
• W2591778805 creator A5072661022 @default.
• W2591778805 date "2017-06-01" @default.
• W2591778805 modified "2023-10-18" @default.
• W2591778805 title "Preclinical Mammalian Safety Studies of EPHARNA (DOPC Nanoliposomal EphA2-Targeted siRNA)" @default.
• W2591778805 cites W1580639099 @default.
• W2591778805 cites W1594899067 @default.
• W2591778805 cites W1611419331 @default.
• W2591778805 cites W1647075334 @default.
• W2591778805 cites W1768148184 @default.
• W2591778805 cites W1917023326 @default.
• W2591778805 cites W1925841406 @default.
• W2591778805 cites W1967113969 @default.
• W2591778805 cites W1975001648 @default.
• W2591778805 cites W1976027235 @default.
• W2591778805 cites W1983055861 @default.
• W2591778805 cites W2008759459 @default.
• W2591778805 cites W2034073392 @default.
• W2591778805 cites W2038894508 @default.
• W2591778805 cites W2040237389 @default.
• W2591778805 cites W2042051990 @default.
• W2591778805 cites W2045029341 @default.
• W2591778805 cites W2052312685 @default.
• W2591778805 cites W2072543946 @default.
• W2591778805 cites W2073018584 @default.
• W2591778805 cites W2075310024 @default.
• W2591778805 cites W2080758920 @default.
• W2591778805 cites W2086973294 @default.
• W2591778805 cites W2088346679 @default.
• W2591778805 cites W2089398124 @default.
• W2591778805 cites W2091260254 @default.
• W2591778805 cites W2094663537 @default.
• W2591778805 cites W2106226793 @default.
• W2591778805 cites W2108613636 @default.
• W2591778805 cites W2129825215 @default.
• W2591778805 cites W2145159785 @default.
• W2591778805 cites W2161611906 @default.
• W2591778805 cites W2171109371 @default.
• W2591778805 cites W2443402937 @default.
• W2591778805 cites W2516271598 @default.
• W2591778805 cites W4255524696 @default.
• W2591778805 doi "https://doi.org/10.1158/1535-7163.mct-16-0541" @default.
• W2591778805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5457703" @default.
• W2591778805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28265009" @default.
• W2591778805 hasPublicationYear "2017" @default.
• W2591778805 type Work @default.
• W2591778805 sameAs 2591778805 @default.
• W2591778805 citedByCount "83" @default.
• W2591778805 countsByYear W25917788052017 @default.
• W2591778805 countsByYear W25917788052018 @default.
• W2591778805 countsByYear W25917788052019 @default.
• W2591778805 countsByYear W25917788052020 @default.
• W2591778805 countsByYear W25917788052021 @default.
• W2591778805 countsByYear W25917788052022 @default.
• W2591778805 countsByYear W25917788052023 @default.
• W2591778805 crossrefType "journal-article" @default.
• W2591778805 hasAuthorship W2591778805A5009234043 @default.
• W2591778805 hasAuthorship W2591778805A5010129570 @default.
• W2591778805 hasAuthorship W2591778805A5012481606 @default.
• W2591778805 hasAuthorship W2591778805A5015483526 @default.
• W2591778805 hasAuthorship W2591778805A5020081483 @default.
• W2591778805 hasAuthorship W2591778805A5023542865 @default.
• W2591778805 hasAuthorship W2591778805A5027588399 @default.
• W2591778805 hasAuthorship W2591778805A5034494201 @default.
• W2591778805 hasAuthorship W2591778805A5037364493 @default.
• W2591778805 hasAuthorship W2591778805A5066527642 @default.
• W2591778805 hasAuthorship W2591778805A5072661022 @default.
• W2591778805 hasBestOaLocation W25917788051 @default.
• W2591778805 hasConcept C112705442 @default.
• W2591778805 hasConcept C126322002 @default.
• W2591778805 hasConcept C137061746 @default.
• W2591778805 hasConcept C150903083 @default.
• W2591778805 hasConcept C185592680 @default.
• W2591778805 hasConcept C197934379 @default.
• W2591778805 hasConcept C19831878 @default.
• W2591778805 hasConcept C202751555 @default.
• W2591778805 hasConcept C207001950 @default.
• W2591778805 hasConcept C2776190711 @default.
• W2591778805 hasConcept C2777288759 @default.
• W2591778805 hasConcept C2777495288 @default.
• W2591778805 hasConcept C2780035454 @default.
• W2591778805 hasConcept C2780091579 @default.
• W2591778805 hasConcept C2780512811 @default.
• W2591778805 hasConcept C29730261 @default.
• W2591778805 hasConcept C55493867 @default.
• W2591778805 hasConcept C57992300 @default.
• W2591778805 hasConcept C71924100 @default.

• next